Corbus Pharmaceuticals I... (CRBP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
12.08
0.63 (5.50%)
At close: Jan 15, 2025, 12:28 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -0.59 | -0.25 | -1.66 | -0.88 | -5.05 | -5.98 | -10.99 | -17.38 | -5.84 | -23.73 | -128.51 | -23.54 |
PS Ratio | n/a | n/a | 85.93 | 24.81 | 9.65 | 69.03 | 146.00 | 181.86 | 79.78 | n/a | n/a | n/a |
PB Ratio | -3.79 | 0.42 | 1.10 | 2.16 | 56.66 | 12.09 | 6.17 | 38.97 | 5.76 | 10.28 | -43.41 | -105.25 |
P/FCF Ratio | -0.72 | -0.37 | -1.57 | -0.98 | -7.2 | -10.28 | -12.5 | -24.96 | -10.86 | -24.85 | -211.08 | -27.13 |
P/OCF Ratio | -0.72 | -0.37 | -1.57 | -0.98 | -7.63 | -11.07 | -12.82 | -25.61 | -11.13 | -25.53 | -211.08 | -27.13 |
OCF/S Ratio | n/a | n/a | -54.65 | -25.32 | -1.26 | -6.24 | -11.39 | -7.1 | -7.17 | n/a | n/a | n/a |
Debt / Equity Ratio | -3.02 | 0.76 | 0.38 | 0.59 | 1.53 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | -0.36 | n/a |
Quick Ratio | 0.74 | 4.76 | 5.89 | 2.88 | 1.17 | 2.45 | 7.98 | 1.96 | 3.50 | 8.85 | 0.47 | 1.97 |
Current Ratio | 0.74 | 4.76 | 5.89 | 2.89 | 1.09 | 2.45 | 7.98 | 1.96 | 3.50 | 8.85 | 0.47 | 1.97 |
Asset Turnover | n/a | n/a | 0.01 | 0.04 | 0.74 | 0.10 | 0.04 | 0.11 | 0.05 | n/a | n/a | n/a |
Interest Coverage | -15.42 | -18.68 | -30.59 | -119.42 | -4.05K | n/a | -177.83 | n/a | -3.63K | -110.2 | -12.35 | n/a |
Return on Equity (ROE) | 6.46 | -1.69 | -0.66 | -2.46 | -11.23 | -2.02 | -0.56 | -2.24 | -0.99 | -0.43 | 0.34 | 4.47 |
Return on Assets (ROA) | -1.58 | -0.84 | -0.42 | -1.09 | -1.41 | -1.18 | -0.48 | -1.12 | -0.69 | -0.38 | -1.97 | -1.63 |
Return on Capital (ROIC) | 12.45 | -0.74 | -0.62 | -1.74 | -5.41 | -1.96 | -0.55 | -2.22 | -0.96 | -0.45 | 1.62 | -3.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | -85.92% | 97.50% | 99.75% | -908.11% | -967.09% | -707.6% | -808.21% | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -5.17K% | -2.83K% | -191.33% | -1.15K% | -1.33K% | -1.05K% | -1.37K% | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -5.18K% | -2.83K% | -197.69% | -1.15K% | -1.33K% | -1.05K% | -1.37K% | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -6.35K% | -3.12K% | -213.33% | -1.18K% | -1.33K% | -1.05K% | -1.37K% | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -5.47K% | -2.54K% | -134.09% | -671.21% | -1.17K% | -728.48% | -734.37% | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -6.23K% | -3.09K% | -211.28% | -1.17K% | -1.32K% | -1.04K% | -1.36K% | n/a | n/a | n/a |